Signal active
Investment Firm
Overview
CMEA closed in April of 2015 and has unveiled its new corporate identity as Presidio Partners. CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries.
CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today's technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.
Highlights
1989
Venture Capital
1-10
96
19
41
Early Stage Venture, Late Stage Venture, Seed
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
CMEA Capital, established in 1989 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Social Media, Software, SaaS, Recruiting, Analytics, Human Resources, Cloud Computing, Enterprise Software, Crowdsourcing, Virtual Workforce. The organization boasts a portfolio of 96 investments, with an average round size of $22.8M and 41 successful exits. Their recent investments include Jobvite, Liveops, Menlo Ventures, Benchmark, SpikeSource. The highest investment round they participated in was $135.3B. Among their most notable exits are Jobvite and Liveops. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
96
8
19
41
Investments
96
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
May 15, 2014 | Sorbent Therapeutics | Biotechnology | 6.5M |
Oct 07, 2014 | Jobvite | Social Media | 25.0M |
Apr 20, 2015 | Cnano Technology | Energy | 15.0M |
May 01, 2015 | - | - | 14.3M |
Exits
41
Funding Timeline
96
0
1
Funding Rounds
96
CMEA Capital has raised 96 rounds. Their latest funding was raised on May 01, 2015 from a Series A - VYNE Therapeutics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
May 15, 2014 | Series D - Sorbent Therapeutics | - | 6.5M | - |
Oct 07, 2014 | Series D - Jobvite | - | 25.0M | - |
Apr 20, 2015 | Series B - Cnano Technology | - | 15.0M | - |
May 01, 2015 | Series A - VYNE Therapeutics | - | 14.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.